Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 101

1.

IL1 Receptor Antagonist Controls Transcriptional Signature of Inflammation in Patients with Metastatic Breast Cancer.

Wu TC, Xu K, Martinek J, Young RR, Banchereau R, George J, Turner J, Kim KI, Zurawski S, Wang X, Blankenship D, Brookes HM, Marches F, Obermoser G, Lavecchio E, Levin MK, Bae S, Chung CH, Smith JL, Cepika AM, Oxley KL, Snipes GJ, Banchereau J, Pascual V, O'Shaughnessy J, Palucka AK.

Cancer Res. 2018 Sep 15;78(18):5243-5258. doi: 10.1158/0008-5472.CAN-18-0413. Epub 2018 Jul 16.

2.

Corrigendum: Development and function of human innate immune cells in a humanized mouse model.

Rongvaux A, Willinger T, Martinek J, Strowig T, Gearty SV, Teichmann LL, Saito Y, Marches F, Halene S, Palucka AK, Manz MG, Flavell RA.

Nat Biotechnol. 2017 Dec 8;35(12):1211. doi: 10.1038/nbt1217-1211c. No abstract available.

PMID:
29220023
3.

The chromatin accessibility signature of human immune aging stems from CD8+ T cells.

Ucar D, Márquez EJ, Chung CH, Marches R, Rossi RJ, Uyar A, Wu TC, George J, Stitzel ML, Palucka AK, Kuchel GA, Banchereau J.

J Exp Med. 2017 Oct 2;214(10):3123-3144. doi: 10.1084/jem.20170416. Epub 2017 Sep 13.

4.

Constitutive resistance to viral infection in human CD141+ dendritic cells.

Silvin A, Yu CI, Lahaye X, Imperatore F, Brault JB, Cardinaud S, Becker C, Kwan WH, Conrad C, Maurin M, Goudot C, Marques-Ladeira S, Wang Y, Pascual V, Anguiano E, Albrecht RA, Iannacone M, García-Sastre A, Goud B, Dalod M, Moris A, Merad M, Palucka AK, Manel N.

Sci Immunol. 2017 Jul 7;2(13). pii: eaai8071. doi: 10.1126/sciimmunol.aai8071.

5.

Targeting dendritic cells in humanized mice receiving adoptive T cells via monoclonal antibodies fused to Flu epitopes.

Graham JP, Authie P, Yu CI, Zurawski SM, Li XH, Marches F, Flamar AL, Acharya A, Banchereau J, Palucka AK.

Vaccine. 2016 Sep 22;34(41):4857-4865. doi: 10.1016/j.vaccine.2016.08.071. Epub 2016 Aug 29.

6.

ICOS(+)PD-1(+)CXCR3(+) T follicular helper cells contribute to the generation of high-avidity antibodies following influenza vaccination.

Bentebibel SE, Khurana S, Schmitt N, Kurup P, Mueller C, Obermoser G, Palucka AK, Albrecht RA, Garcia-Sastre A, Golding H, Ueno H.

Sci Rep. 2016 May 27;6:26494. doi: 10.1038/srep26494.

7.

Expansion and Activation of CD103(+) Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition.

Salmon H, Idoyaga J, Rahman A, Leboeuf M, Remark R, Jordan S, Casanova-Acebes M, Khudoynazarova M, Agudo J, Tung N, Chakarov S, Rivera C, Hogstad B, Bosenberg M, Hashimoto D, Gnjatic S, Bhardwaj N, Palucka AK, Brown BD, Brody J, Ginhoux F, Merad M.

Immunity. 2016 Apr 19;44(4):924-38. doi: 10.1016/j.immuni.2016.03.012.

8.

The Human Vaccines Project: A roadmap for cancer vaccine development.

Romero P, Banchereau J, Bhardwaj N, Cockett M, Disis ML, Dranoff G, Gilboa E, Hammond SA, Hershberg R, Korman AJ, Kvistborg P, Melief C, Mellman I, Palucka AK, Redchenko I, Robins H, Sallusto F, Schenkelberg T, Schoenberger S, Sosman J, Türeci Ö, Van den Eynde B, Koff W, Coukos G.

Sci Transl Med. 2016 Apr 13;8(334):334ps9. doi: 10.1126/scitranslmed.aaf0685. Review.

PMID:
27075624
9.

The Basis of Oncoimmunology.

Palucka AK, Coussens LM.

Cell. 2016 Mar 10;164(6):1233-1247. doi: 10.1016/j.cell.2016.01.049. Review.

10.

Consensus nomenclature for CD8+ T cell phenotypes in cancer.

Apetoh L, Smyth MJ, Drake CG, Abastado JP, Apte RN, Ayyoub M, Blay JY, Bonneville M, Butterfield LH, Caignard A, Castelli C, Cavallo F, Celis E, Chen L, Colombo MP, Comin-Anduix B, Coukos G, Dhodapkar MV, Dranoff G, Frazer IH, Fridman WH, Gabrilovich DI, Gilboa E, Gnjatic S, Jäger D, Kalinski P, Kaufman HL, Kiessling R, Kirkwood J, Knuth A, Liblau R, Lotze MT, Lugli E, Marincola F, Melero I, Melief CJ, Mempel TR, Mittendorf EA, Odun K, Overwijk WW, Palucka AK, Parmiani G, Ribas A, Romero P, Schreiber RD, Schuler G, Srivastava PK, Tartour E, Valmori D, van der Burg SH, van der Bruggen P, van den Eynde BJ, Wang E, Zou W, Whiteside TL, Speiser DE, Pardoll DM, Restifo NP, Anderson AC.

Oncoimmunology. 2015 Feb 25;4(4):e998538. eCollection 2015 Apr.

11.

A novel vaccine for mantle cell lymphoma based on targeting cyclin D1 to dendritic cells via CD40.

Chen J, Zurawski G, Zurawski S, Wang Z, Akagawa K, Oh S, Hideki U, Fay J, Banchereau J, Song W, Palucka AK.

J Hematol Oncol. 2015 Apr 14;8:35. doi: 10.1186/s13045-015-0131-7.

12.

Classification of current anticancer immunotherapies.

Galluzzi L, Vacchelli E, Bravo-San Pedro JM, Buqué A, Senovilla L, Baracco EE, Bloy N, Castoldi F, Abastado JP, Agostinis P, Apte RN, Aranda F, Ayyoub M, Beckhove P, Blay JY, Bracci L, Caignard A, Castelli C, Cavallo F, Celis E, Cerundolo V, Clayton A, Colombo MP, Coussens L, Dhodapkar MV, Eggermont AM, Fearon DT, Fridman WH, Fučíková J, Gabrilovich DI, Galon J, Garg A, Ghiringhelli F, Giaccone G, Gilboa E, Gnjatic S, Hoos A, Hosmalin A, Jäger D, Kalinski P, Kärre K, Kepp O, Kiessling R, Kirkwood JM, Klein E, Knuth A, Lewis CE, Liblau R, Lotze MT, Lugli E, Mach JP, Mattei F, Mavilio D, Melero I, Melief CJ, Mittendorf EA, Moretta L, Odunsi A, Okada H, Palucka AK, Peter ME, Pienta KJ, Porgador A, Prendergast GC, Rabinovich GA, Restifo NP, Rizvi N, Sautès-Fridman C, Schreiber H, Seliger B, Shiku H, Silva-Santos B, Smyth MJ, Speiser DE, Spisek R, Srivastava PK, Talmadge JE, Tartour E, Van Der Burg SH, Van Den Eynde BJ, Vile R, Wagner H, Weber JS, Whiteside TL, Wolchok JD, Zitvogel L, Zou W, Kroemer G.

Oncotarget. 2014 Dec 30;5(24):12472-508. Review.

13.

Human CD141+ dendritic cells induce CD4+ T cells to produce type 2 cytokines.

Yu CI, Becker C, Metang P, Marches F, Wang Y, Toshiyuki H, Banchereau J, Merad M, Palucka AK.

J Immunol. 2014 Nov 1;193(9):4335-43. doi: 10.4049/jimmunol.1401159. Epub 2014 Sep 22. Erratum in: J Immunol. 2014 Dec 15;193(12):6210.

14.

IFN priming is necessary but not sufficient to turn on a migratory dendritic cell program in lupus monocytes.

Rodriguez-Pla A, Patel P, Maecker HT, Rossello-Urgell J, Baldwin N, Bennett L, Cantrell V, Baisch J, Punaro M, Gotte A, Nassi L, Wright T, Palucka AK, Banchereau J, Pascual V.

J Immunol. 2014 Jun 15;192(12):5586-98. doi: 10.4049/jimmunol.1301319. Epub 2014 May 14.

15.

Development and function of human innate immune cells in a humanized mouse model.

Rongvaux A, Willinger T, Martinek J, Strowig T, Gearty SV, Teichmann LL, Saito Y, Marches F, Halene S, Palucka AK, Manz MG, Flavell RA.

Nat Biotechnol. 2014 Apr;32(4):364-72. doi: 10.1038/nbt.2858. Epub 2014 Mar 16. Erratum in: Nat Biotechnol. 2017 Dec 8;35(12 ):1211.

16.

Molecular signatures of antibody responses derived from a systems biology study of five human vaccines.

Li S, Rouphael N, Duraisingham S, Romero-Steiner S, Presnell S, Davis C, Schmidt DS, Johnson SE, Milton A, Rajam G, Kasturi S, Carlone GM, Quinn C, Chaussabel D, Palucka AK, Mulligan MJ, Ahmed R, Stephens DS, Nakaya HI, Pulendran B.

Nat Immunol. 2014 Feb;15(2):195-204. doi: 10.1038/ni.2789. Epub 2013 Dec 15.

17.

Linking genome and immunity.

Palucka AK, Pulendran B.

Curr Opin Immunol. 2013 Oct;25(5):549-50. doi: 10.1016/j.coi.2013.10.001. Epub 2013 Oct 15. No abstract available.

PMID:
24139582
18.

Induction of ICOS+CXCR3+CXCR5+ TH cells correlates with antibody responses to influenza vaccination.

Bentebibel SE, Lopez S, Obermoser G, Schmitt N, Mueller C, Harrod C, Flano E, Mejias A, Albrecht RA, Blankenship D, Xu H, Pascual V, Banchereau J, Garcia-Sastre A, Palucka AK, Ramilo O, Ueno H.

Sci Transl Med. 2013 Mar 13;5(176):176ra32. doi: 10.1126/scitranslmed.3005191.

19.

Neutralizing tumor-promoting chronic inflammation: a magic bullet?

Coussens LM, Zitvogel L, Palucka AK.

Science. 2013 Jan 18;339(6117):286-91. doi: 10.1126/science.1232227. Review. Erratum in: Science. 2013 Mar 29;339(6127):1522.

20.

Targeting self- and foreign antigens to dendritic cells via DC-ASGPR generates IL-10-producing suppressive CD4+ T cells.

Li D, Romain G, Flamar AL, Duluc D, Dullaers M, Li XH, Zurawski S, Bosquet N, Palucka AK, Le Grand R, O'Garra A, Zurawski G, Banchereau J, Oh S.

J Exp Med. 2012 Jan 16;209(1):109-21. doi: 10.1084/jem.20110399. Epub 2012 Jan 2.

21.

[Harnessing myeloid dendritic cell subsets in novel cancer immunotherapy].

Ueno H, Fay J, Palucka AK, Banchereau J.

Rinsho Ketsueki. 2011 Jul;52(7):505-13. Review. Japanese. No abstract available.

PMID:
21821982
22.

Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers.

Butterfield LH, Palucka AK, Britten CM, Dhodapkar MV, Håkansson L, Janetzki S, Kawakami Y, Kleen TO, Lee PP, Maccalli C, Maecker HT, Maino VC, Maio M, Malyguine A, Masucci G, Pawelec G, Potter DM, Rivoltini L, Salazar LG, Schendel DJ, Slingluff CL Jr, Song W, Stroncek DF, Tahara H, Thurin M, Trinchieri G, van Der Burg SH, Whiteside TL, Wigginton JM, Marincola F, Khleif S, Fox BA, Disis ML.

Clin Cancer Res. 2011 May 15;17(10):3064-76. doi: 10.1158/1078-0432.CCR-10-2234. Epub 2011 May 10. Review.

23.

Thymic stromal lymphopoietin fosters human breast tumor growth by promoting type 2 inflammation.

Pedroza-Gonzalez A, Xu K, Wu TC, Aspord C, Tindle S, Marches F, Gallegos M, Burton EC, Savino D, Hori T, Tanaka Y, Zurawski S, Zurawski G, Bover L, Liu YJ, Banchereau J, Palucka AK.

J Exp Med. 2011 Mar 14;208(3):479-90. doi: 10.1084/jem.20102131. Epub 2011 Feb 21.

24.

Development of a HIV-1 lipopeptide antigen pulsed therapeutic dendritic cell vaccine.

Cobb A, Roberts LK, Palucka AK, Mead H, Montes M, Ranganathan R, Burkeholder S, Finholt JP, Blankenship D, King B, Sloan L, Harrod AC, Lévy Y, Banchereau J.

J Immunol Methods. 2011 Feb 28;365(1-2):27-37. doi: 10.1016/j.jim.2010.11.002. Epub 2010 Nov 18.

PMID:
21093448
25.

Concomitant activation and antigen uptake via human dectin-1 results in potent antigen-specific CD8+ T cell responses.

Ni L, Gayet I, Zurawski S, Duluc D, Flamar AL, Li XH, O'Bar A, Clayton S, Palucka AK, Zurawski G, Banchereau J, Oh S.

J Immunol. 2010 Sep 15;185(6):3504-13. doi: 10.4049/jimmunol.1000999. Epub 2010 Aug 20.

26.

The expanding family of dendritic cell subsets.

Ueno H, Palucka AK, Banchereau J.

Nat Biotechnol. 2010 Aug;28(8):813-5. doi: 10.1038/nbt0810-813. No abstract available.

PMID:
20697407
27.

Longitudinal tracking of human dendritic cells in murine models using magnetic resonance imaging.

Briley-Saebo KC, Leboeuf M, Dickson S, Mani V, Fayad ZA, Palucka AK, Banchereau J, Merad M.

Magn Reson Med. 2010 Nov;64(5):1510-9. doi: 10.1002/mrm.22519.

28.

Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR.

Klechevsky E, Flamar AL, Cao Y, Blanck JP, Liu M, O'Bar A, Agouna-Deciat O, Klucar P, Thompson-Snipes L, Zurawski S, Reiter Y, Palucka AK, Zurawski G, Banchereau J.

Blood. 2010 Sep 9;116(10):1685-97. doi: 10.1182/blood-2010-01-264960. Epub 2010 Jun 7.

29.

Dendritic cells and humoral immunity in humans.

Ueno H, Schmitt N, Palucka AK, Banchereau J.

Immunol Cell Biol. 2010 May-Jun;88(4):376-80. doi: 10.1038/icb.2010.28. Epub 2010 Mar 23. Review.

30.

Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in Oncology.

Tahara H, Sato M, Thurin M, Wang E, Butterfield LH, Disis ML, Fox BA, Lee PP, Khleif SN, Wigginton JM, Ambs S, Akutsu Y, Chaussabel D, Doki Y, Eremin O, Fridman WH, Hirohashi Y, Imai K, Jacobson J, Jinushi M, Kanamoto A, Kashani-Sabet M, Kato K, Kawakami Y, Kirkwood JM, Kleen TO, Lehmann PV, Liotta L, Lotze MT, Maio M, Malyguine A, Masucci G, Matsubara H, Mayrand-Chung S, Nakamura K, Nishikawa H, Palucka AK, Petricoin EF, Pos Z, Ribas A, Rivoltini L, Sato N, Shiku H, Slingluff CL, Streicher H, Stroncek DF, Takeuchi H, Toyota M, Wada H, Wu X, Wulfkuhle J, Yaguchi T, Zeskind B, Zhao Y, Zocca MB, Marincola FM.

J Transl Med. 2009 Jun 17;7:45. doi: 10.1186/1479-5876-7-45.

31.

CD2 distinguishes two subsets of human plasmacytoid dendritic cells with distinct phenotype and functions.

Matsui T, Connolly JE, Michnevitz M, Chaussabel D, Yu CI, Glaser C, Tindle S, Pypaert M, Freitas H, Piqueras B, Banchereau J, Palucka AK.

J Immunol. 2009 Jun 1;182(11):6815-23. doi: 10.4049/jimmunol.0802008.

32.

Understanding human myeloid dendritic cell subsets for the rational design of novel vaccines.

Klechevsky E, Liu M, Morita R, Banchereau R, Thompson-Snipes L, Palucka AK, Ueno H, Banchereau J.

Hum Immunol. 2009 May;70(5):281-8. doi: 10.1016/j.humimm.2009.02.004. Epub 2009 Feb 21.

33.

Influenza virus and poly(I:C) inhibit MHC class I-restricted presentation of cell-associated antigens derived from infected dead cells captured by human dendritic cells.

Frleta D, Yu CI, Klechevsky E, Flamar AL, Zurawski G, Banchereau J, Palucka AK.

J Immunol. 2009 Mar 1;182(5):2766-76. doi: 10.4049/jimmunol.0801720.

34.

A systematic approach to biomarker discovery; preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers".

Butterfield LH, Disis ML, Fox BA, Lee PP, Khleif SN, Thurin M, Trinchieri G, Wang E, Wigginton J, Chaussabel D, Coukos G, Dhodapkar M, Håkansson L, Janetzki S, Kleen TO, Kirkwood JM, Maccalli C, Maecker H, Maio M, Malyguine A, Masucci G, Palucka AK, Potter DM, Ribas A, Rivoltini L, Schendel D, Seliger B, Selvan S, Slingluff CL Jr, Stroncek DF, Streicher H, Wu X, Zeskind B, Zhao Y, Zocca MB, Zwierzina H, Marincola FM.

J Transl Med. 2008 Dec 23;6:81. doi: 10.1186/1479-5876-6-81.

35.

Dendritic cells: a critical player in cancer therapy?

Palucka AK, Ueno H, Fay J, Banchereau J.

J Immunother. 2008 Nov-Dec;31(9):793-805. doi: 10.1097/CJI.0b013e31818403bc. Review.

36.

Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells.

Klechevsky E, Morita R, Liu M, Cao Y, Coquery S, Thompson-Snipes L, Briere F, Chaussabel D, Zurawski G, Palucka AK, Reiter Y, Banchereau J, Ueno H.

Immunity. 2008 Sep 19;29(3):497-510. doi: 10.1016/j.immuni.2008.07.013.

37.

Broad influenza-specific CD8+ T-cell responses in humanized mice vaccinated with influenza virus vaccines.

Yu CI, Gallegos M, Marches F, Zurawski G, Ramilo O, García-Sastre A, Banchereau J, Palucka AK.

Blood. 2008 Nov 1;112(9):3671-8. doi: 10.1182/blood-2008-05-157016. Epub 2008 Aug 19.

38.

A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus.

Chaussabel D, Quinn C, Shen J, Patel P, Glaser C, Baldwin N, Stichweh D, Blankenship D, Li L, Munagala I, Bennett L, Allantaz F, Mejias A, Ardura M, Kaizer E, Monnet L, Allman W, Randall H, Johnson D, Lanier A, Punaro M, Wittkowski KM, White P, Fay J, Klintmalm G, Ramilo O, Palucka AK, Banchereau J, Pascual V.

Immunity. 2008 Jul 18;29(1):150-64. doi: 10.1016/j.immuni.2008.05.012.

39.

How the study of children with rheumatic diseases identified interferon-alpha and interleukin-1 as novel therapeutic targets.

Pascual V, Allantaz F, Patel P, Palucka AK, Chaussabel D, Banchereau J.

Immunol Rev. 2008 Jun;223:39-59. doi: 10.1111/j.1600-065X.2008.00643.x. Review.

40.

Tumour immunity: effector response to tumour and role of the microenvironment.

Mantovani A, Romero P, Palucka AK, Marincola FM.

Lancet. 2008 Mar 1;371(9614):771-83. doi: 10.1016/S0140-6736(08)60241-X. Epub 2008 Feb 13. Review.

PMID:
18275997
41.

Dendritic cells and cytokines in human inflammatory and autoimmune diseases.

Blanco P, Palucka AK, Pascual V, Banchereau J.

Cytokine Growth Factor Rev. 2008 Feb;19(1):41-52. doi: 10.1016/j.cytogfr.2007.10.004. Review.

42.

Circulating tumor antigen-specific regulatory T cells in patients with metastatic melanoma.

Vence L, Palucka AK, Fay JW, Ito T, Liu YJ, Banchereau J, Ueno H.

Proc Natl Acad Sci U S A. 2007 Dec 26;104(52):20884-9. Epub 2007 Dec 18.

43.

Taming cancer by inducing immunity via dendritic cells.

Palucka AK, Ueno H, Fay JW, Banchereau J.

Immunol Rev. 2007 Dec;220:129-50. Review.

PMID:
17979844
44.

Interactions of tumor cells with dendritic cells: balancing immunity and tolerance.

Dhodapkar MV, Dhodapkar KM, Palucka AK.

Cell Death Differ. 2008 Jan;15(1):39-50. Epub 2007 Oct 19. Review.

45.

Dendritic cell subsets in health and disease.

Ueno H, Klechevsky E, Morita R, Aspord C, Cao T, Matsui T, Di Pucchio T, Connolly J, Fay JW, Pascual V, Palucka AK, Banchereau J.

Immunol Rev. 2007 Oct;219:118-42. Review.

PMID:
17850486
46.

Both Langerhans cells and interstitial DC cross-present melanoma antigens and efficiently activate antigen-specific CTL.

Cao T, Ueno H, Glaser C, Fay JW, Palucka AK, Banchereau J.

Eur J Immunol. 2007 Sep;37(9):2657-67.

47.

Humanized mice for the development and testing of human vaccines.

Aspord C, Yu CI, Banchereau J, Palucka AK.

Expert Opin Drug Discov. 2007 Jul;2(7):949-60. doi: 10.1517/17460441.2.7.949.

PMID:
23484815
48.

IL-15-induced human DC efficiently prime melanoma-specific naive CD8+ T cells to differentiate into CTL.

Dubsky P, Saito H, Leogier M, Dantin C, Connolly JE, Banchereau J, Palucka AK.

Eur J Immunol. 2007 Jun;37(6):1678-90.

49.

Breast cancer instructs dendritic cells to prime interleukin 13-secreting CD4+ T cells that facilitate tumor development.

Aspord C, Pedroza-Gonzalez A, Gallegos M, Tindle S, Burton EC, Su D, Marches F, Banchereau J, Palucka AK.

J Exp Med. 2007 May 14;204(5):1037-47. Epub 2007 Apr 16.

50.

Supplemental Content

Loading ...
Support Center